[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GT200300249A - Administracion dermica de un inhibidor de ciclooxigenasa-2 selectivo soluble en agua - Google Patents

Administracion dermica de un inhibidor de ciclooxigenasa-2 selectivo soluble en agua

Info

Publication number
GT200300249A
GT200300249A GT200300249A GT200300249A GT200300249A GT 200300249 A GT200300249 A GT 200300249A GT 200300249 A GT200300249 A GT 200300249A GT 200300249 A GT200300249 A GT 200300249A GT 200300249 A GT200300249 A GT 200300249A
Authority
GT
Guatemala
Prior art keywords
cyclooxygenasa
dermic
inhibitor
administration
water soluble
Prior art date
Application number
GT200300249A
Other languages
English (en)
Inventor
Gary D Ewing
Guang Wei Lu
Brenda M Stoller
Kathryn M Kienle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200300249A publication Critical patent/GT200300249A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA COMPOSICION FARMACEUTICA PARA LA APLICACION SOBRE UN AREA DE PIEL PARA TRATAMIENTO LOCAL Y/O SISTEMICO DE UN TRASTORNO MEDIADO POR COX2 QUE COMPRENDE UNA LAMINA DE SOPORTE QUE SE PUEDE ADAPTAR FLEXIBLEMENTE AL AREA DE PIEL QUE PERMITE LA LIBERACION TRANSDERMICA DE UNA CANTIDAD TERAPEUTICA DEL AGENTE ACTIVO.
GT200300249A 2002-11-21 2003-11-20 Administracion dermica de un inhibidor de ciclooxigenasa-2 selectivo soluble en agua GT200300249A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42820102P 2002-11-21 2002-11-21

Publications (1)

Publication Number Publication Date
GT200300249A true GT200300249A (es) 2004-07-12

Family

ID=32393362

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200300249A GT200300249A (es) 2002-11-21 2003-11-20 Administracion dermica de un inhibidor de ciclooxigenasa-2 selectivo soluble en agua

Country Status (15)

Country Link
US (1) US20040126415A1 (es)
EP (1) EP1572166A1 (es)
JP (1) JP2006509759A (es)
AR (1) AR042102A1 (es)
AU (1) AU2003291386A1 (es)
BR (1) BR0316463A (es)
CA (1) CA2506628A1 (es)
GT (1) GT200300249A (es)
MX (1) MXPA05004989A (es)
NL (1) NL1024830C2 (es)
PA (1) PA8589001A1 (es)
PE (1) PE20041026A1 (es)
TW (1) TW200503787A (es)
UY (1) UY28086A1 (es)
WO (1) WO2004047814A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1610742B1 (en) * 2003-04-10 2015-01-21 Neurogesx, Inc. Uses and compositions for administration of capsaicin
US7666914B2 (en) * 2004-06-03 2010-02-23 Richlin David M Topical preparation and method for transdermal delivery and localization of therapeutic agents
US20060204561A1 (en) * 2005-02-14 2006-09-14 Naweed Muhammad Device for delivery of TRPV1 agonists
EP1865933B1 (en) * 2005-03-30 2015-11-04 Vanderbilt Royalty Sub L.P. Low-concentration capsaicin patch and methods for treating neuropathic pain
DE102005050431A1 (de) * 2005-10-21 2007-04-26 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreicherung lipophiler und/oder wenig hautpermeabler Wirkstoffe
US20090081281A1 (en) * 2006-05-10 2009-03-26 Gerard Farmer Photosensitizer Formulation for Topical Applications
DE102006054732B4 (de) * 2006-11-21 2010-12-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren
JP4327841B2 (ja) * 2006-12-20 2009-09-09 日東電工株式会社 経皮吸収製剤の製造装置および製造方法
EP2278947A4 (en) * 2008-05-21 2013-11-06 Teikoku Pharma Usa Inc TREATMENT OF DYSMENORRHEA BY TRANSDERMAL ADMINISTRATION OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
JP2012020991A (ja) * 2010-06-16 2012-02-02 Takasago Internatl Corp 経皮吸収促進剤、及びこれを含有する皮膚外用製剤
US9814911B2 (en) * 2011-07-15 2017-11-14 Robert Benson Aylor Skin and hair treatments
ES2758198T3 (es) * 2014-11-10 2020-05-04 Achelios Therapeutics Inc Composiciones analgésicas pulverizables
KR102042456B1 (ko) * 2018-03-22 2019-11-08 크리스탈지노믹스(주) 경피흡수제제

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0892791T3 (da) * 1996-04-12 2003-06-23 Searle & Co N-[[4-(5-methyl-3-phenylisoxazol-4-yl]-phenyl]-sulfonylpropylamid og dets natriumsalt som prodrugs for COX-2-inhibitorer
AU718811B2 (en) * 1996-10-30 2000-04-20 Theratech, Inc. Fatty acid esters of glycolic acid and its salts as permeation enhancers
ES2197077T3 (es) * 1999-03-01 2004-01-01 Amarin Technologies S.A. Dispositivo transdermico que comprende farmacos anti-inflamatorios no esteroides incorporados en una matriz de un polimero acrilico adhesivo.
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
IN191512B (es) * 2000-01-21 2003-12-06 Panacea Biotech
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
WO2002078625A2 (en) * 2001-03-28 2002-10-10 Pharmacia Corporation Therapeutic combinations for cardiovascular and inflammatory indications
MXPA03010991A (es) * 2001-05-31 2004-02-27 Pharmacia Corp Composicion permeable a la piel que comprende inhibidor de ciclooxigenasa-a selectivo y alcohol monohidrico.
JP4283507B2 (ja) * 2002-08-02 2009-06-24 久光製薬株式会社 経皮投与用貼付剤

Also Published As

Publication number Publication date
MXPA05004989A (es) 2005-08-02
AR042102A1 (es) 2005-06-08
JP2006509759A (ja) 2006-03-23
PA8589001A1 (es) 2005-02-04
EP1572166A1 (en) 2005-09-14
UY28086A1 (es) 2004-06-30
WO2004047814A1 (en) 2004-06-10
AU2003291386A1 (en) 2004-06-18
BR0316463A (pt) 2005-10-11
US20040126415A1 (en) 2004-07-01
PE20041026A1 (es) 2005-02-05
NL1024830C2 (nl) 2006-03-06
NL1024830A1 (nl) 2004-05-26
TW200503787A (en) 2005-02-01
CA2506628A1 (en) 2004-06-10

Similar Documents

Publication Publication Date Title
AR029716A1 (es) Productos dermatologicos en forma de hoja
GT200300247A (es) Lamina revestida de adhesivo para administracion dermica de un inhibidor selectivo de ciclooxigenasa-2
GT200300249A (es) Administracion dermica de un inhibidor de ciclooxigenasa-2 selectivo soluble en agua
CL2004000931A1 (es) Pelicula consumible adaptada para adherirse y disolverse en la cavidad bucal que comprende un almidon modificado y un agente farmaceuticamente activo.
ECSP045102A (es) Formulación farmacéutica que contiene 3-(3-dimetilamino-1-etil-2-metil-propil)fenol y proporciona una liberación retardada del ingrediente activo
AR033761A1 (es) Banda adhesiva
AR052854A1 (es) Metodo para reducir la inflamacion del tejido oral utilizando extracto de magnolia
ES2151968T3 (es) Composiciones hemorroidales y metodo de utilizacion.
ES2159591T3 (es) Composicion de liberacion controlada.
NO20011471D0 (no) Nye orale vedvarende frigivelsesformuleringer
ES2077530B1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
AR055838A1 (es) Formulaciones para microproyecciones recubiertas que tienen solubilidad controlada
GT199900180AA (es) Composicion farmacéutica para ser aplicada a las mucosas .
BRPI0415986A (pt) método e aparelho para reduzir a incidência do uso de tabaco
PE20150773A1 (es) Composiciones farmaceuticas para la liberacion sostenida de fenilefrina
ES2168241T1 (es) Preparacion farmaceutica que contiene tolperisona para administrar por via oral.
AR026040A1 (es) Sistema terapeutico transdermal que contiene clorhidrato de tulobuterol para la administracion del broncodilatador tulobuterol a traves de la piel
ES2164310T3 (es) Comprimidos matriciales para uso oral y de liberacion prolongada que contienen la sal sodica de la tianeptina.
BRPI0406858A (pt) Liberação controlada de agentes altamente solúveis
NO20073575L (no) Farmasoytiske sammensetninger for behandling av cellulitt
AR025792A1 (es) Formulaciones orales de liberacion controlada
BR0215068A (pt) Dispositivo para cuidar de feridas
PA8615501A1 (es) Formulaciones farmaceuticas transdermicas
AR040515A1 (es) Formula farmaceutica topica estabilizada con contenido de ketoprofeno
BR9910201A (pt) Sistema terapêutico transdérmico para emprego de candesartan